The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
PAAB eFiles Tag and CEI Report 2024
-
Hello @Manufacturer and @Agency .
Please find uploaded the completed Tag report and CEI report for Q1 of 2024. We saw an 18.5% CEI completion rate in Q1. We hope to watch this number grow. Please let us know if you have any questions.
Have a great week.
